The WAPPS-Hemo Team
February 5, 2021
WAPPS News
The WAPPS-Hemo Team
November 2, 2020
Introducing new Eloctate (one-stage) Population PK models on WAPPS-Hemo.
Two new models (Model 1: using fat-free mass and age information; Model 2: using fat-free mass, age and blood group information) were developed in order to expand the previous Eloctate models along the age continuum.
The WAPPS-Hemo Team
September 1, 2020
New function released today – Modelling of variable dose regimen.
We are pleased to announce some added features to WAPPS-Hemo with the latest update.
The WAPPS-Hemo Team
August 20, 2020
What’s New in version 5.2 WAPPS-Hemo
Version 5.2 of WAPPS-Hemo introduces a large set of minor incremental updates, many on the back-end, to make our human validation more efficient, many in the connectivity to external software and applications, and many to the look and general functionalities.
The WAPPS-Hemo Team
July 22, 2020
Launch of McMaster PopPK, a new CE-marked PK tool
For WAPPS-Hemo users located in Europe, McMaster is excited to announce the launch of McMaster PopPK. If you see value in using a CE-marked platform, then McMaster PopPK is now available for you. This new CE-marked platform provides individual pharmacokinetic parameters based on the trusted WAPPS-Hemo engine. McMaster PopPK is CE-marked as an in vitro diagnostic device class I in accordance with the EU IVD Directive. McMaster PopPK supports myWAPPS and florioTM to display estimated factor levels via patient smartphone apps.
The WAPPS-Hemo Team
July 13, 2020
At WAPPS-News we post the latest updates and changes to the WAPPS-Hemo program. Check back with us regularly. Contact us if you have any questions.
The WAPPS-HEMO Team
